Jeevan Scientific Technology has informed that USFDA conducted an un-announced audit of its Bioanalytical facility in Hyderabad. The purpose of this audit was to review the BA/BE studies conducted at its facilities. The auditors started the review on 20th January, 2020 and completed on 24th January, 2020 Audit concluded with ‘No Observations’ and Auditors are pleased with company procedures. This Audit is specifically to access and approve the bioequivalence studies conducted by JSTL for Pharmaceutical companies across the globe.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| TCS | 2581.65 |
| Infosys | 1318.60 |
| HCL Tech. | 1442.50 |
| Wipro | 204.35 |
| Tech Mahindra | 1511.85 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: